2 studies found for:    ((Ganetespib AND GIST) OR NCT01039519 OR NCT00687934 OR NCT00688116 OR NCT01183364) | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors
Condition: Solid Tumors
Intervention: Drug: STA 9090 (ganetespib)
2 Recruiting A Dose Escalation Study of STA-9090 and Docetaxel in Patients With Solid Tumors
Condition: Solid Tumor Malignancies
Intervention: Drug: STA-9090 (ganetespib) with Docetaxel

Indicates status has not been verified in more than two years